Connect with:
Wednesday / November 20. 2024
HomePosts Tagged "Dr Seva Rostovtsev"

Registration dossiers were submitted in India, Brazil, the Philippines, the United States, Colombia, South Korea, Peru and Taiwan.

FMC Corporation, a leading agricultural sciences company, recently submitted regulatory applications for Dodhylex™ active herbicide in eight rice-growing countries. Registration dossiers were submitted in India, Brazil, the Philippines, the United States, Colombia, South Korea, Peru and Taiwan, which account for approximately 35 per cent of the estimated 165 million hectares of planted rice globally. Regulatory submissions for Dodhylex™ active are planned in additional key global markets.

Dodhylex™ active, FMC’s brand name for tetflupyrolimet, has been classified by the Herbicide Resistance Action Committee (HRAC) and the Weed Science Society of America (WSSA) as a Group 28 herbicide, making it the first new mode of action herbicide globally in over three decades. Dodhylex™ active will be an important new rotational tool for growers to manage herbicide resistance, which poses an increasing challenge for growers worldwide.

“Dodhylex™ active is a significant advancement for the agriculture industry as it will help combat resistant grass weeds,” said Dr Seva Rostovtsev, FMC executive vice president and chief technology officer. “This is particularly remarkable because rice is a grass, and controlling grass weeds in a grass crop is challenging.”

Studies show this proprietary molecule will offer season-long control of resistant grass weeds in rice, regardless of the cultivation method. FMC continues to research the use of Dodhylex™ active in additional crops, including sugarcane, wheat, soybean and corn.

“Dodhylex™ active is one of many new active ingredients in our robust development pipeline that will contribute to FMC’s near and long-term growth,” said Brian P. Angeli, FMC executive vice president and chief marketing officer. “There are opportunities to control resistant grass weeds in other crops, and we are exploring additional markets for Dodhylex™ active outside of rice. We believe this will expand our global addressable market in the future.”

Dodhylex™ active, which was discovered and developed at FMC’s Stine Research Center, is a testament to FMC’s commitment to innovation and disciplined approach to advancing new molecules to help combat resistance and support food security for a growing population. Pending regulatory decisions, FMC anticipates the first launches of Dodhylex™ active in 2026.

Registration dossiers were submitted in India, Brazil,

The agreement aims to bolster FMC’s position as the market leader in insecticides and AgroSpheres’ speed to market for its ribonucleic acid (RNA) portfolio.

FMC Corporation, a leading global agricultural sciences company, announced a research agreement with AgroSpheres, a biotechnology company pioneering breakthroughs in sustainable crop protection and crop health. The agreement will accelerate the discovery and development of novel bioinsecticides, which is a key part of FMC’s long-range strategic plan.

The agreement aims to bolster FMC’s position as the market leader in insecticides and AgroSpheres’ speed to market for its ribonucleic acid (RNA) portfolio by pairing AgroSpheres’ production and formulation technology with FMC’s high throughput testing, evaluation, and go-to-market capabilities. In 2023, FMC Ventures invested in AgroSpheres, a startup developing biodegradable micro-encapsulation technology to improve the delivery, stability and efficacy of biological crop protection products based on RNA interference (RNAi) technology.

“Our research agreement with AgroSpheres marks a significant milestone in FMC’s commitment to advancing sustainable agriculture through innovation,” said Dr Seva Rostovtsev, FMC executive vice president and chief technology officer. “We believe RNAi can provide a suite of powerful new tools for the crop protection market and that AgroSpheres has built a powerful platform to discover and manufacture these new technologies. This collaboration is a testament to our dedication to innovation and excellence in crop protection. It underscores our belief in the power of partnership to drive agricultural science forward, ensuring a healthier planet for future generations.”

RNAi biomolecules have demonstrated great promise in the lab but have struggled to yield consistent results for commercial biological development. AgroSpheres’ patented AgriCell manufacturing technology allows for the expression of a wide array of RNA molecules while yielding consistent results. AgroSpheres’ production of encapsulated RNA biomolecules delivers enhanced stability, performance and targeted uptake in pests. AgroSpheres’ groundbreaking biomodality approach targets specific, yet diverse, biological actions, efficiently multiplying product offerings and innovation.

In a global market desperately in need of effective tools to combat resistance, FMC has shown foresight by investing in next-generation technologies and setting aggressive goals to meet demand for high-performance biologicals,” said Ameer Shakeel, founder and chief technology officer of AgroSpheres. “As leaders in bringing molecules to market, they are an ideal partner for AgroSpheres as we progress to comprehensive product development. We are excited to codevelop with the FMC team.”

The agreement aims to bolster FMC's position